Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer December 2022 20(6):510-514 - Subject
- Language
- ISSN
- 1558-7673